| References |
|
|
Alexander SPH,
Mathie A and
Peters JA
(2009)
Guide to receptors and channels (GRAC), 4th edn.
British Journal of Pharmacology
158(suppl. 1):
S11–S13.
|
|
|
Aloyo VJ,
Berg KA,
Spampinato U,
Clarke WP and
Harvey JA
(2009)
Current status of inverse agonism at serotonin2a (5-HT2a) and 5-HT2c receptors.
Pharmacology & Therapeutics
121:
160–173.
|
|
| ePath
Andrade R,
Barnes NM,
Baxter G et al.
(2009) 5-Hydroxytryptamine receptors. IUPHAR database (IUPHAR-DB). http://www.iuphar-db.org/PRODDATABASE/FamilyMenuForward?familyId=1.
|
|
|
Barnes NM,
Hales TG,
Lummis SCR and
Peters JA
(2009)
The 5-HT3 receptor – the relationship between structure and function.
Neuropharmacology
56:
273–284.
|
|
|
Bender E,
Pindon A,
Van Oers I et al.
(2000)
Structure of the human serotonin 5-HT4 receptor gene and cloning of a novel 5-HT4 splice variant.
Journal of Neurochemistry
74:
478–489.
|
|
|
Berger M,
Gray JA and
Roth BL
(2009)
The expanded biology of serotonin.
Annual Review of Medicine
60:
355–366.
|
|
|
Bockaert J,
Claeysen S,
Becamel C,
Dumuis A and
Marin P
(2006)
Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation.
Cell Tissue Research
326:
553–572.
|
|
|
Bockaert J,
Claeysen S,
Compan V and
Dumuis A
(2008)
5-HT4 receptors: history, molecular pharmacology and brain functions.
Neuropharmacology
55:
922–931.
|
|
|
Bradley PB,
Engel G,
Feniuk W et al.
(1986)
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine.
Neuropharmacology
25:
563–576.
|
|
|
Burns CM,
Chu H,
Rueter SM et al.
(1997)
Regulation of serotonin-2C receptor G-protein coupling by RNA editing.
Nature
387:
303–308.
|
|
|
Camilleri M
(2009)
Serotonin in the gastrointestinal tract.
Current Opinion in Endocrinology, Diabetes and Obesity
16:
53–59.
|
|
|
Clarke DE,
Craig DA and
Fozard JR
(1989)
The 5-HT4 receptor: naughty but nice.
Trends in Pharmacological Sciences
10:
385–386.
|
|
|
Filip M and
Bader M
(2009)
Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system.
Pharmacological Reports
61:
761–777.
|
|
|
Fone KCF
(2008)
An update on the role of the 5-hydroxytryptamine(6) receptor in cognitive function.
Neuropharmacology
55:
1015–1022.
|
|
|
Gaddum JH and
Picarelli ZP
(1957)
Two kinds of tryptamine receptor.
British Journal of Pharmacology and Chemotherapy
12:
323–328.
|
|
|
Gannon RL,
Peglion JL and
Milian MJ
(2009)
Differential influence of selective 5-HT5a vs 5-HT1a, 5-HT1b, or 5-HT2c receptor blockade upon light-induced phase shifts in circadian activity rhythms: interaction studies with citalopram.
European Neuropsychopharmacology
19:
887–897.
|
|
|
Hannon J and
Hoyer D
(2008)
Molecular biology of 5-HT receptors.
Behavioural Brain Research
195:
198–213.
|
|
|
Hartig P,
Hoyer D,
Humphrey PPA and
Martin G
(1996)
Alignment of receptor nomenclature with the human genome. Effects on classification of 5-HT1D/5-HT1B receptor subtypes.
Trends in Pharmacological Sciences
17:
103–105.
|
|
|
Hartig PR,
Branchek TA and
Weinshank RL
(1992)
A subfamily of 5-HT1D receptor genes.
Trends in Pharmacological Sciences
13:
152–159.
|
|
|
Hoyer D,
Clarke DE,
Fozard JR et al.
(1994)
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin).
Pharmacological Reviews
46:
157–204.
|
|
|
Hoyer D,
Hannon JP and
Martin GR
(2002)
Molecular, pharmacological and functional diversity of 5-HT receptors.
Pharmacology Biochemistry and Behavior
71:
533–554.
|
|
|
Hoyer D and
Martin GR
(1997)
5-HT receptor classification and nomenclature: towards a harmonization with the human genome.
Neuropharmacology
36:
419–428.
|
|
|
Humphrey PPA,
Hartig PR and
Hoyer D
(1993)
A new nomenclature for 5-HT receptors.
Trends in Pharmacological Sciences
14:
233–236.
|
|
|
Kasper S and
Hamon M
(2009)
Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.
World Journal of Biological Psychiatry
10:
117–126.
|
|
|
Keiser MJ,
Setola V,
Irwin JJ et al.
(2009)
Predicting new molecular targets for known drugs.
Nature
462:
175–181.
|
|
|
Maclean M R and
Dempsie Y
(2009)
Serotonin and pulmonary hypertension – from bench to bedside?
Current Opinion in Pharmacology
9:
281–286.
|
|
|
Massot O,
Rouselle J-C,
Fillion M-P et al.
(1996)
5-Hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
Molecular Pharmacology
50:
752–762.
|
|
|
book
Mengod G,
Cortés R,
Vilaró M T and
Hoyer D
(2010)
"Distribution of 5-HT receptors in the central nervous system".
In: C Mueller and
B Jacobs (eds)
Handbook of the Behavioral Neurobiology of Serotonin,
pp. 123–138.
Amsterdam: Academic Press/Elsevier.
|
|
|
Meneses M
(2008)
Role of serotonin systems in learning and memory.
Behavioural Brain Research
195.
|
|
|
Millan M J
(2009)
Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs.
Neurotherapeutics
6:
53–77.
|
|
|
Millan MJ,
Marin P,
Bockaert J and
La Cour CM
(2008)
Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions.
Trends in Pharmacological Sciences
29:
454–464.
|
|
|
book
Monti Bloch J,
Pandi-Perumal SR,
Jacobs BL and
Nutt D
(2008)
Serotonin and Sleep: Molecular, Functional and Clinical Aspects.
Basel, Switzerland: Birkhauser Verlag AG.
|
|
|
Nichols DE and
Nichols CD
(2008)
Serotonin receptors.
Chemical Reviews
108:
1614–1641.
|
|
|
Niesler B,
Walstab J,
Combrink S et al.
(2007)
Characterization of the novel human serotonin receptor subunits 5-HT3c, 5-HT3d, and 5-HT3e.
Molecular Pharmacology
72:
8–17.
|
|
|
Rothman RB and
Baumann MH
(2009)
Serotonergic drugs and valvular heart disease.
Expert Opinion on Drug Safety
8:
317–329.
|
|
|
Sanger GJ
(2008)
5-hydroxytryptamine and the gastrointestinal tract: where next?
Trends in Pharmacological Sciences
29:
465–471.
|
|
|
Sanger GJ
(2009)
Translating 5-HT4 receptor pharmacology.
Journal of Neurogastroenterology and Motility
21:
1235–1238.
|
|
|
book
Shireman BT,
Bonaventure P and
Carruthers NI
(2008)
"Recent advances on the 5-HT5a, 5-HT6 and 5-HT7 receptors".
In: Annual Reports in Medicinal Chemistry,
vol. 43.
San Diego: Elsevier Academic Press.
|
|
|
Thomas DR
(2006)
5-HT(5a) receptors as a therapeutic target.
Pharmacology & Therapeutics
111:
707–714.
|
|
|
Upton N,
Chuang TT,
Hunter AJ and
Virley DJ
(2008)
5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease.
Neurotherapeutics
5:
458–469.
|
|
|
Villalon CM and
Centurion D
(2007)
Cardiovascular responses produced by 5-hydroxytriptamine: a pharmacological update on the receptors/mechanisms involved and therapeutic implications.
Naunyn-Schmiedebergs Archives of Pharmacology
376:
45–63.
|
|
|
Werry TD,
Loiacono R,
Sexton PM and
Christopoulos A
(2008)
RNA editing of the serotonin 5HT(2c) receptor and its effects on cell signalling, pharmacology and brain function.
Pharmacology & Therapeutics
119:
7–23.
|
| Further Reading |
|
|
Baumgarten HG and
Goethert M
(1997)
Serotoninergic neurons and 5-HT receptors in the CNS.
Handbook of Experimental Pharmacology
129.
|
|
|
book
Martin GR,
Eglen RM,
Hoyer D,
Hamblin MW and
Yocca F (eds)
(1998)
Advances in Serotonin Receptor Research: Molecular Biology, Signal Transduction, and Therapeutics, 297pp.
New York: New York Academy of Sciences.
(Proceedings of a Conference held 8–10 October 1997, in San Francisco, California.) [In: Annals of the New York Academy of Science 861].
|
|
|
book
Mueller C and
Jacobs B
(2010)
Handbook of the Behavioral Neurobiology of Serotonin.
Amsterdam: Academic Press/Elsevier.
|
|
| other
Whitaker Azmitia PM and
Peroutka SJ (eds)
(1989) The neuropharmacology of serotonin. Annals of the New York Academy of Sciences 600.
|
